GPCR News 

Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards

Meet Peter McNamara, Ph.D., Tectonic’s SVP, Head of Research

Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences

Addex Raises $10 Million In Equity Financing

Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain

Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...

VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron

Crinetics Pharmaceuticals announced the formation of an independently operated new company...

Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist

Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...

First in Human: Early-stage COVID therapies hold promise against omicron variant

OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...

Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...

Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets

Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...

Dr. Thomas P. Sakmar receives an honorary doctorate from Karolinska Institute

Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...

Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19...

Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European ...

Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team